COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 1 vs. Not present] |
Hazard ratio: 3.510 (1.530-8.020)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum creatinine [Abnormal at admission vs. Normal] |
Hazard ratio: 2.040 (1.320-3.150)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum creatinine [Abnormal vs. Normal] |
Hazard ratio: 3.090 (1.950-4.870)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Blood urea nitrogen [Abnormal at admission vs. Normal] |
Hazard ratio: 7.150 (4.920-10.390)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum creatinine [Abnormal at admission vs. Normal] |
Hazard ratio: 2.990 (2.000-4.470)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Serum creatinine [Abnormal vs. Normal] |
Hazard ratio: 5.880 (3.900-8.870)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Haematuria Negative 2+^3+ [2+^3+ vs. Negative] |
Hazard ratio: 12.200 (6.320-23.530)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Blood urea nitrogen [Abnormal at admission vs. Normal] |
Hazard ratio: 4.200 (2.740-6.450)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Hematuria Negative 1+ [1+ vs. Negative] |
Hazard ratio: 4.640 (2.240-9.620)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Haematuria Negative 2+^3+ [2+^3+ vs. Negative] |
Hazard ratio: 8.890 (4.410-17.940)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Proteinuria Negative 2+^3+ [2+^3+ vs. Negative] |
Hazard ratio: 10.920 (5.000-23.860)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Hematuria Negative 1+ [1+ vs. Negative] |
Hazard ratio: 3.050 (1.430-6.490)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Proteinuria negative 1+ [1+ vs. Negative] |
Hazard ratio: 4.120 (1.970-8.620)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Proteinuria Negative 2+^3+ [2+^3+ vs. Negative] |
Hazard ratio: 6.800 (2.970-15.560)
§ |
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Lymphocytes [Abnormal vs. Normal] |
Hazard ratio: 1.020 (0.700-1.480)
|
Cheng
|
|
|
COVID-19 (death) |
Laboratory Findings |
Proteinuria negative 1+ [1+ vs. Negative] |
Hazard ratio: 2.470 (1.150-5.330)
§ |
Cheng
|
|
|
COVID-19 (death) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Hazard ratio: 1.060 (0.730-1.540)
|
Cheng
|
|
|
COVID-19 (death) |
Status |
Disease severity [Severe disease vs. Non-severe disease] |
Hazard ratio: 6.100 (3.860-9.640)
|
Cheng
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 2.150 (1.450-3.210)
|
Cheng
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>65 years vs. <=65 years] |
Hazard ratio: 2.430 (1.660-3.560)
|
Cheng
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding during hospitalization [Appearance of ground-glass or consolidation vs. Not present] |
Odds ratio: 6.280 (3.900-10.100)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Creatinine [Abnormal vs. Normal] |
Odds ratio: 1.030 (1.000-1.050)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocytes [1 unit increase vs. Not applicable] |
Odds ratio: 0.260 (0.090-0.700)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Nausea and vomiting [Present vs. Not present] |
Odds ratio: 15.550 (2.860-84.200)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Shortness of breath [Present vs. Not present] |
Odds ratio: 9.020 (2.200-37.010)
§ |
Zhang
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Muscle ache [Present vs. Not present] |
Odds ratio: 4.670 (1.750-12.460)
§ |
Zhang
|
|
|
COVID-19 (death) |
Laboratory Findings |
CD3+CD8+ T cells [Abnormal vs. Normal] |
Odds ratio: 3.980 (1.130-14.010)
§ |
Du
|
|
|
COVID-19 (death) |
Comorbidities |
Cardiovascular or cerebrovascular disease [Present vs. Not present] |
Odds ratio: 2.460 (0.760-8.040)
§† |
Du
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>=65 years vs. < 65 years] |
Odds ratio: 3.770 (1.150-17.390)
§ |
Du
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Irregular right middle lobe vs. Normal] |
Odds ratio: 3.570 (0.950-13.440)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Irregular right upper lobe vs. Normal] |
Odds ratio: 5.600 (1.200-26.280)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Abnormal Bronchial wall thickening vs. Normal] |
Odds ratio: 32.590 (7.880-134.880)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Abnormal Linear opacities vs. Normal] |
Odds ratio: 10.020 (2.160-46.450)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [Abnormal Crazy-paving pattern vs. Normal] |
Odds ratio: 3.340 (1.260-8.880)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [High Consolidated tissue vs. Normal] |
Odds ratio: 6.390 (1.720-23.720)
|
Li
|
|
|
COVID-19 (severe/critical) |
Findings |
Radiological finding on admission [CT score >7 vs. CT score <=7] |
Odds ratio: 19.200 (5.820-63.340)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Oxyhemoglobin saturation [Abnormal vs. Normal] |
Odds ratio: 8.330 (2.480-27.930)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Procalcitonin [Abnormal vs. Normal] |
Odds ratio: 7.990 (2.430-26.310)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
CRP [Abnormal vs. Normal] |
Odds ratio: 13.200 (2.850-61.240)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocyte count decreased [Present vs. Not present] |
Odds ratio: 12.000 (3.210-44.820)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Monocyte ratio decreased [Present vs. Not present] |
Odds ratio: 18.000 (2.040-159.190)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphocyte ratio [Present vs. Not present] |
Odds ratio: 7.600 (2.480-23.280)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Neutrophil ratio increased [Present vs. Not present] |
Odds ratio: 9.680 (3.280-28.580)
|
Li
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Sputum production [Present vs. Not present] |
Odds ratio: 4.880 (1.510-15.790)
|
Li
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Cough [Present vs. Not present] |
Odds ratio: 9.950 (1.250-79.550)
|
Li
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Chest pain [Present vs. Not present] |
Odds ratio: 10.860 (1.150-102.770)
|
Li
|
|
|
COVID-19 (severe/critical) |
Symptoms |
Dyspnea [Present vs. Not present] |
Odds ratio: 10.900 (2.070-57.200)
|
Li
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Any comorbidity [Present vs. Not present] |
Odds ratio: 10.610 (2.930-38.400)
|
Li
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [>50 years vs. <=50 years] |
Odds ratio: 7.600 (2.660-21.660)
|
Li
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
D-dimer [1 unit increase vs. Not applicable] |
Weighted Mean Difference: 0.670 (0.020-1.320)
|
Xu
|
|
|